EUVIMEDEUVIMED entdecken
Crossref

L26/O-277 Low-grade inflammation and euploid pregnancy loss

L.E. Vexø, I. Behrendt-Møller, T.K. Vomstein, D. Glintborg, M. Nyegaard, L. Ambye, J.R. Grühn, K. Banasik, N.B. Brandt, S.J. Bonnema, P. Kamstrup, S. Bliddal und 2 weitere

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von L.E. Vexø und 13 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Among women with pregnancy loss, is persistent low-grade inflammation, reflected by elevated high-sensitivity C-reactive protein (hs-CRP), associated with euploid rather than aneuploid pregnancy loss? Summary answer Women with persistently elevated hs-CRP levels were more likely to have experienced a euploid rather than an aneuploid pregnancy loss. What is known already The underlying causes for euploid pregnancy losses remain largely unknown. Maternal immune regulation during pregnancy is complex, shifting between pro- and anti-inflammatory responses, and disruption in this balance can lead to pregnancy complications. Low-grade inflammation, reflected by hs-CRP, creates a persistent inflammatory environment in the body. Previous studies have shown that higher pre-conception hs-CRP levels are associated with increased risk of pregnancy loss, and one small pilot study demonstrated that elevated hs-CRP levels were associated with euploid pregnancy loss. Therefore, low-grade inflammation may be an unidentified risk factor for euploid pregnancy loss. Study design, size, duration We conducted a prospective cohort study, including 3051 women experiencing an intrauterine pregnancy loss, before gestational week 22. Women were included between November 2020, until May 2025. Recruitment occurred at four Danish university hospitals. All included women provided written informed consent after receiving oral and written information about the study. Participants/materials, setting, methods Women were included at the time of pregnancy loss diagnosis. Hs-CRP levels were measured at inclusion and follow-up 4-8 weeks after the pregnancy loss. Pregnancy tissue was collected during treatment procedure and fetal ploidy was determined by cell-free-fetal DNA or fetal tissue sequencing. Only women with available hs-CRP measurements and fetal ploidy results were included in this study. Logistic regression models were adjusted for age, BMI, gestational age, sample storage duration, and days between visits. Main results and the role of chance Among 2763 women with complete data on hs-CRP and fetal ploidy, 1483 (54%) experienced a euploid pregnancy loss and 1280 (46%) experienced an aneuploid pregnancy loss. Median hs-CRP levels were 1.4 mg/L at inclusion, and 0.64 mg/L at follow-up. To distinguish persistent low-grade inflammation from acute inflammatory responses, included women were grouped based on their hs-CRP levels at inclusion and follow-up. Women with persistent low-grade inflammation (hs-CRP ≥ 2 mg/L at both visits), had a significantly higher risk of euploid pregnancy loss versus aneuploid pregnancy loss, compared to women within the reference group (hs-CRP < 2 mg/L at both visits) (OR 1.55, 95% CI: 1.10;1.95). A similar association was found in women with acute inflammatory response (hs-CRP ≥ 2 mg/L at inclusion, < 2 mg/L at follow-up) (OR 1.3, 95% CI: 1.02; 1.7). Among all included women, higher hs-CRP levels on the day of pregnancy loss diagnosis were associated with greater odds of euploid pregnancy loss, both when analyzed as a continuous variable (OR: 1.07, 95% CI: 1.03;1.12), and as a categoric variable, comparing women with hs-CRP levels between 2-10 mg/L, to women with hs-CRP levels <2 mg/L (OR: 1.39, 95% CI: 1.16;1.66). Limitations, reasons for caution Our findings are observational, and cannot establish causality. While the follow-up sample serve as a baseline, the absence of pre-conception hs-CRP measurements in our study prevents us from determining whether low-grade inflammation existed before pregnancy or developed in response to the pregnancy loss. Wider implications of the findings A better understanding of the mechanisms and risk factors leading to euploid pregnancy loss, could potentially help prevent future losses. Elevated hs-CRP levels indicating low-grade inflammation may serve as a screening biomarker to identify women who could benefit from anti-inflammatory interventions to prevent future euploid pregnancy losses. Trial registration number No

Zitieren

APA

Vexø, L., Behrendt-Møller, I., Vomstein, T., Glintborg, D., Nyegaard, M., Ambye, L., Grühn, J., Banasik, K., Brandt, N., Bonnema, S., Kamstrup, P., Bliddal, S., Westergaard, D., & Nielsen, H. (2026). L26/O-277 Low-grade inflammation and euploid pregnancy loss. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.275

Vancouver

Vexø L, Behrendt-Møller I, Vomstein T, Glintborg D, Nyegaard M, Ambye L, et al. L26/O-277 Low-grade inflammation and euploid pregnancy loss. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.275

BibTeX
@article{Vex2026,
  author = {Vexø, L.E. and Behrendt-Møller, I. and Vomstein, T.K. and Glintborg, D. and Nyegaard, M. and Ambye, L. and Grühn, J.R. and Banasik, K. and Brandt, N.B. and Bonnema, S.J. and Kamstrup, P. and Bliddal, S. and Westergaard, D. and Nielsen, H.S.},
  title = {L26/O-277 Low-grade inflammation and euploid pregnancy loss},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.275}
}
Kostenlos starten →